Valeant Pharmaceuticals

Valeant Pharmaceuticals International (NYSE: VRX) is a global, research-based, specialty pharmaceutical company that discovers, develops, manufactures and markets pharmaceutical products, primarily in the areas of neurology, dermatology and infectious disease. Valeant has made rapid strides under a new management team that laid out a strategic vision with a renewed focus on its specialty pharmaceuticals business, and has implemented major changes in the areas of product management, business development, research and development, corporate governance and supply chain operations.